ISA Pharmaceuticals BV ▲ Sign in to save

• ▲ Cornelis J.M. Melief

  ISA Pharmaceuticals (Netherlands) Immunology and Microbiology
  33.1k

  citations

  87

  h-index

  28

  Aachen papers
• ▲ Kitty M.C. Kwappenberg

  ISA Pharmaceuticals (Netherlands) Immunology and Microbiology
  3k

  citations

  22

  h-index

  2

  Aachen papers
• ▲ Willem-Jan Krebber

  ISA Pharmaceuticals (Netherlands) Immunology and Microbiology
  2.98k

  citations

  10

  h-index

  9

  Aachen papers
• ▲ Cornelius J. M. Melief

  ISA Pharmaceuticals (Netherlands) Immunology and Microbiology
  1.54k

  citations

  13

  h-index

  1

  Aachen papers
• ▲ Anna‐Sophia Wiekmeijer

  ISA Pharmaceuticals (Netherlands) Immunology and Microbiology
  679

  citations

  10

  h-index

  8

  Aachen papers
• ▲ Gijs G. Zom

  Genmab (Netherlands) Immunology and Microbiology
  673

  citations

  15

  h-index

  4

  Aachen papers
• ▲ Thomas J. M. Beenakker

  ISA Pharmaceuticals (Netherlands) Chemistry
  457

  citations

  13

  h-index

  9

  Aachen papers

7 results

• A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection

  2022 Nature Communications article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 2 patents

  54

  citations
• Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients

  2020 Antiviral Research article Immunology and Microbiology Immunotherapy and Immune Responses Open access

  21

  citations
• Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides

  2023 Cancer Immunology Immunotherapy article Immunology and Microbiology Immunotherapy and Immune Responses Open access

  10

  citations
• A third vaccination with a single T cell epitope protects against SARS-CoV-2 infection in the absence of neutralizing antibodies

  2021 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine SARS-CoV-2 and COVID-19 Research Open access

  1

  citations
• Supplementary Figure Legends from Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates

  2023 supplementary-materials Immunology and Microbiology Immunotherapy and Immune Responses Open access

  0

  citations

5 results